866-997-4948(US-Canada Toll Free)

Global Adalimumab Sales Market Report 2016

Published By :

QYResearch

Published Date : Nov 2016

Category :

Pharmaceutical

No. of Pages : 101 Pages

Notes:
Sales, means the sales volume of Adalimumab
Revenue, means the sales value of Adalimumab

This report studies sales (consumption) of Adalimumab in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Janssen Biotech
GlaxoSmithKline
Sanofi
MedImmune
UCB
Novartis
Delenex Therapeutics
Ablynx
Sandoz
Zydus Cadila
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Adalimumab in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Adalimumab in each application, can be divided into
Application 1
Application 2
Application 3

Table of Contents

Global Adalimumab Sales Market Report 2016
1 Adalimumab Overview
1.1 Product Overview and Scope of Adalimumab
1.2 Classification of Adalimumab
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Adalimumab
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Adalimumab Market by Regions
1.4.1 United States Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Adalimumab (2011-2021)
1.5.1 Global Adalimumab Sales and Growth Rate (2011-2021)
1.5.2 Global Adalimumab Revenue and Growth Rate (2011-2021)

2 Global Adalimumab Competition by Manufacturers, Type and Application
2.1 Global Adalimumab Market Competition by Manufacturers
2.1.1 Global Adalimumab Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Adalimumab Revenue and Share by Manufacturers (2011-2016)
2.2 Global Adalimumab (Volume and Value) by Type
2.2.1 Global Adalimumab Sales and Market Share by Type (2011-2016)
2.2.2 Global Adalimumab Revenue and Market Share by Type (2011-2016)
2.3 Global Adalimumab (Volume and Value) by Regions
2.3.1 Global Adalimumab Sales and Market Share by Regions (2011-2016)
2.3.2 Global Adalimumab Revenue and Market Share by Regions (2011-2016)
2.4 Global Adalimumab (Volume) by Application

3 United States Adalimumab (Volume, Value and Sales Price)
3.1 United States Adalimumab Sales and Value (2011-2016)
3.1.1 United States Adalimumab Sales and Growth Rate (2011-2016)
3.1.2 United States Adalimumab Revenue and Growth Rate (2011-2016)
3.1.3 United States Adalimumab Sales Price Trend (2011-2016)
3.2 United States Adalimumab Sales and Market Share by Manufacturers
3.3 United States Adalimumab Sales and Market Share by Type
3.4 United States Adalimumab Sales and Market Share by Application

4 China Adalimumab (Volume, Value and Sales Price)
4.1 China Adalimumab Sales and Value (2011-2016)
4.1.1 China Adalimumab Sales and Growth Rate (2011-2016)
4.1.2 China Adalimumab Revenue and Growth Rate (2011-2016)
4.1.3 China Adalimumab Sales Price Trend (2011-2016)
4.2 China Adalimumab Sales and Market Share by Manufacturers
4.3 China Adalimumab Sales and Market Share by Type
4.4 China Adalimumab Sales and Market Share by Application

5 Europe Adalimumab (Volume, Value and Sales Price)
5.1 Europe Adalimumab Sales and Value (2011-2016)
5.1.1 Europe Adalimumab Sales and Growth Rate (2011-2016)
5.1.2 Europe Adalimumab Revenue and Growth Rate (2011-2016)
5.1.3 Europe Adalimumab Sales Price Trend (2011-2016)
5.2 Europe Adalimumab Sales and Market Share by Manufacturers
5.3 Europe Adalimumab Sales and Market Share by Type
5.4 Europe Adalimumab Sales and Market Share by Application

6 Japan Adalimumab (Volume, Value and Sales Price)
6.1 Japan Adalimumab Sales and Value (2011-2016)
6.1.1 Japan Adalimumab Sales and Growth Rate (2011-2016)
6.1.2 Japan Adalimumab Revenue and Growth Rate (2011-2016)
6.1.3 Japan Adalimumab Sales Price Trend (2011-2016)
6.2 Japan Adalimumab Sales and Market Share by Manufacturers
6.3 Japan Adalimumab Sales and Market Share by Type
6.4 Japan Adalimumab Sales and Market Share by Application

7 Global Adalimumab Manufacturers Analysis
7.1 Janssen Biotech
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Adalimumab Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Janssen Biotech Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
7.1.4 Main Business/Business Overview
7.2 GlaxoSmithKline
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 101 Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 GlaxoSmithKline Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
7.2.4 Main Business/Business Overview
7.3 Sanofi
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 124 Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Sanofi Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
7.3.4 Main Business/Business Overview
7.4 MedImmune
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Nov Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 MedImmune Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
7.4.4 Main Business/Business Overview
7.5 UCB
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 UCB Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
7.5.4 Main Business/Business Overview
7.6 Novartis
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Million USD Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Novartis Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
7.6.4 Main Business/Business Overview
7.7 Delenex Therapeutics
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Pharmaceuticals Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Delenex Therapeutics Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
7.7.4 Main Business/Business Overview
7.8 Ablynx
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Ablynx Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
7.8.4 Main Business/Business Overview
7.9 Sandoz
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Sandoz Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
7.9.4 Main Business/Business Overview
7.10 Zydus Cadila
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2 Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Zydus Cadila Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
7.10.4 Main Business/Business Overview

8 Adalimumab Maufacturing Cost Analysis
8.1 Adalimumab Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Process Analysis of Adalimumab

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Adalimumab Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Adalimumab Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Adalimumab Market Forecast (2016-2021)
12.1 Global Adalimumab Sales, Revenue Forecast (2016-2021)
12.2 Global Adalimumab Sales Forecast by Regions (2016-2021)
12.3 Global Adalimumab Sales Forecast by Type (2016-2021)
12.4 Global Adalimumab Sales Forecast by Application (2016-2021)

13 Appendix
Disclosure Section
Research Methodology
Data Source
China Disclaimer


List of Table

List of Tables and Figures

Figure Picture of Adalimumab
Table Classification of Adalimumab
Figure Global Sales Market Share of Adalimumab by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Adalimumab
Figure Global Sales Market Share of Adalimumab by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Adalimumab Revenue and Growth Rate (2011-2021)
Figure China Adalimumab Revenue and Growth Rate (2011-2021)
Figure Europe Adalimumab Revenue and Growth Rate (2011-2021)
Figure Japan Adalimumab Revenue and Growth Rate (2011-2021)
Figure Global Adalimumab Sales and Growth Rate (2011-2021)
Figure Global Adalimumab Revenue and Growth Rate (2011-2021)
Table Global Adalimumab Sales of Key Manufacturers (2011-2016)
Table Global Adalimumab Sales Share by Manufacturers (2011-2016)
Figure 2015 Adalimumab Sales Share by Manufacturers
Figure 2016 Adalimumab Sales Share by Manufacturers
Table Global Adalimumab Revenue by Manufacturers (2011-2016)
Table Global Adalimumab Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Adalimumab Revenue Share by Manufacturers
Table 2016 Global Adalimumab Revenue Share by Manufacturers
Table Global Adalimumab Sales and Market Share by Type (2011-2016)
Table Global Adalimumab Sales Share by Type (2011-2016)
Figure Sales Market Share of Adalimumab by Type (2011-2016)
Figure Global Adalimumab Sales Growth Rate by Type (2011-2016)
Table Global Adalimumab Revenue and Market Share by Type (2011-2016)
Table Global Adalimumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Adalimumab by Type (2011-2016)
Figure Global Adalimumab Revenue Growth Rate by Type (2011-2016)
Table Global Adalimumab Sales and Market Share by Regions (2011-2016)
Table Global Adalimumab Sales Share by Regions (2011-2016)
Figure Sales Market Share of Adalimumab by Regions (2011-2016)
Figure Global Adalimumab Sales Growth Rate by Regions (2011-2016)
Table Global Adalimumab Revenue and Market Share by Regions (2011-2016)
Table Global Adalimumab Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Adalimumab by Regions (2011-2016)
Figure Global Adalimumab Revenue Growth Rate by Regions (2011-2016)
Table Global Adalimumab Sales and Market Share by Application (2011-2016)
Table Global Adalimumab Sales Share by Application (2011-2016)
Figure Sales Market Share of Adalimumab by Application (2011-2016)
Figure Global Adalimumab Sales Growth Rate by Application (2011-2016)
Figure United States Adalimumab Sales and Growth Rate (2011-2016)
Figure United States Adalimumab Revenue and Growth Rate (2011-2016)
Figure United States Adalimumab Sales Price Trend (2011-2016)
Table United States Adalimumab Sales by Manufacturers (2011-2016)
Table United States Adalimumab Market Share by Manufacturers (2011-2016)
Table United States Adalimumab Sales by Type (2011-2016)
Table United States Adalimumab Market Share by Type (2011-2016)
Table United States Adalimumab Sales by Application (2011-2016)
Table United States Adalimumab Market Share by Application (2011-2016)
Figure China Adalimumab Sales and Growth Rate (2011-2016)
Figure China Adalimumab Revenue and Growth Rate (2011-2016)
Figure China Adalimumab Sales Price Trend (2011-2016)
Table China Adalimumab Sales by Manufacturers (2011-2016)
Table China Adalimumab Market Share by Manufacturers (2011-2016)
Table China Adalimumab Sales by Type (2011-2016)
Table China Adalimumab Market Share by Type (2011-2016)
Table China Adalimumab Sales by Application (2011-2016)
Table China Adalimumab Market Share by Application (2011-2016)
Figure Europe Adalimumab Sales and Growth Rate (2011-2016)
Figure Europe Adalimumab Revenue and Growth Rate (2011-2016)
Figure Europe Adalimumab Sales Price Trend (2011-2016)
Table Europe Adalimumab Sales by Manufacturers (2011-2016)
Table Europe Adalimumab Market Share by Manufacturers (2011-2016)
Table Europe Adalimumab Sales by Type (2011-2016)
Table Europe Adalimumab Market Share by Type (2011-2016)
Table Europe Adalimumab Sales by Application (2011-2016)
Table Europe Adalimumab Market Share by Application (2011-2016)
Figure Japan Adalimumab Sales and Growth Rate (2011-2016)
Figure Japan Adalimumab Revenue and Growth Rate (2011-2016)
Figure Japan Adalimumab Sales Price Trend (2011-2016)
Table Japan Adalimumab Sales by Manufacturers (2011-2016)
Table Japan Adalimumab Market Share by Manufacturers (2011-2016)
Table Japan Adalimumab Sales by Type (2011-2016)
Table Japan Adalimumab Market Share by Type (2011-2016)
Table Japan Adalimumab Sales by Application (2011-2016)
Table Japan Adalimumab Market Share by Application (2011-2016)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Janssen Biotech Adalimumab Global Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Adalimumab Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Adalimumab Global Market Share (2011-2016)
Table MedImmune Basic Information List
Table MedImmune Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MedImmune Adalimumab Global Market Share (2011-2016)
Table UCB Basic Information List
Table UCB Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure UCB Adalimumab Global Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Adalimumab Global Market Share (2011-2016)
Table Delenex Therapeutics Basic Information List
Table Delenex Therapeutics Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Delenex Therapeutics Adalimumab Global Market Share (2011-2016)
Table Ablynx Basic Information List
Table Ablynx Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Ablynx Adalimumab Global Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sandoz Adalimumab Global Market Share (2011-2016)
Table Zydus Cadila Basic Information List
Table Zydus Cadila Adalimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Zydus Cadila Adalimumab Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adalimumab
Figure Manufacturing Process Analysis of Adalimumab
Figure Adalimumab Industrial Chain Analysis
Table Raw Materials Sources of Adalimumab Major Manufacturers in 2015
Table Major Buyers of Adalimumab
Table Distributors/Traders List
Figure Global Adalimumab Sales and Growth Rate Forecast (2016-2021)
Figure Global Adalimumab Revenue and Growth Rate Forecast (2016-2021)
Table Global Adalimumab Sales Forecast by Regions (2016-2021)
Table Global Adalimumab Sales Forecast by Type (2016-2021)
Table Global Adalimumab Sales Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *